Nathan Vardi, Moneyish

Nathan Vardi


New York, NY, United States

Contact Nathan

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Unknown
  • Moneyish
  • Forbes

Past articles by Nathan:

One of the greatest cancer drugs lost its edge. This is why it was vulnerable.

Imbruvica seemed invincible in the marketplace. But a new book, “For Blood and Money,” shows how the drug’s creators left a trap door that led to its undoing. → Read More

This Legendary Billionaire Biotech Investor Has Remained A Mystery—Until Now

In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the boon for countless cancer patients. → Read More

10 crazy things detailed in FTX’s bankruptcy filing

From a $1 billion loan to Sam Bankman-Fried to missing funds and payment-disbursement emojis, here are some of the eye-popping revelations from FTX’s new CEO → Read More

Greg Jensen's big 2022: He succeeded Ray Dalio, nailed inflation, won at poker

‘2023 will likely be the year of a very significant global recession’: Greg Jensen has positioned the world's biggest hedge fund for more market mayhem ahead. He lands on the MarketWatch 50. → Read More

Who are the 50 people influencing markets most this year? Tell us what you think.

We are seeking nominations for the MarketWatch 50, the most influential people in markets in 2022. → Read More

‘It’s a sign of me buying.’ Bill Hwang, the man who manipulated stocks

The indictment of Bill Hwang reveals the mechanics of an operation that drove the trading of certain tech stocks just as today’s Nasdaq plummets → Read More

Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible

Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible → Read More

Inside A Remote Work Billionaire’s New Plan To Turn His White Collar Workers Into Algorithms

To buy one company each week, Joe Liemandt has ordered managers of his 2,500 remote workers to design work units—specialized tasks that workers can perform over and over, as if they were on an old-fashioned auto factory assembly line. → Read More

How Indiana University Bros Fueled A Hollywood Actor’s $690 Million Ponzi Scheme

Started by four Hoosiers, JJMT Capital was the primary investment vehicle for Zachary Horwitz's alleged investment fraud. The original connection was when they were all together at IU. → Read More

How Troubled Trader Bill Hwang Quietly Amassed $10 Billion

Kicked out of Hong Kong and the hedge fund game, Bill Hwang plowed his $500 million net worth into a concentrated portfolio of U.S. internet stocks, like Netflix and Amazon, while shorting Under Armour, to become a trading force. → Read More

America’s Most Feared Trader Lost Billions – Here Are His Picks To Make It Back

Last year, while the U. S. stock market returned 18% during a volatile pandemic bull market, Icahn’s hedge fund plunged by 14%. → Read More

AstraZeneca’s Pascal Soriot Was The Hottest CEO In Pharma. Now He’s In The Hot Seat.

Pascal Soriot's stunning corporate turnaround story at AstraZeneca is now mired in vaccine politics and doubt. → Read More

Pfizer CEO Albert Bourla Helped Save The World. Can He Save His Company’s Stock?

Delivering a game-changing vaccine was a sprint. Bourla says delivering returns for Pfizer shareholders is a marathon. → Read More

Moderna’s Mysterious Coronavirus Vaccine Delivery System

A preprint of preclinical data for Moderna’s coronavirus vaccine suggests it uses delivery technology that is covered by a patent owned by Arbutus and upheld last week. → Read More

Meet The Secretive Wall Street Investor With The Billion Dollar Medicine Cabinet

For 24 years, this former banker quietly purchased small slices of the most expensive and top-selling drugs in the nation and became a billionaire. → Read More

The Man Betting $1 Billion That Pfizer Can Deliver A Vaccine By This Fall

Pfizer's COVID moonshot. Inside an effort that could change the world. → Read More

Financial Technology Startup Cadre Lays Off 25% Of Its Employees

Cadre joins a growing list of high-profile technology companies like Airbnb and Uber that have laid off a large number of employees amid the pandemic → Read More

EXCLUSIVE: AstraZeneca’s Calquence Shows Early Promise For COVID-19 Patients

The blood cancer drug has been given to a small number of sick U.S. patients and massive clinical trials are being launched to determine its efficacy, as well as that of Imbruvica. → Read More

The Winning And Losing Hedge Funds Of The March Pandemic

One of Pierre Andurand's hedge funds was up 122% in the first quarter; Boaz Weinstein's fund was up 72%. Ray Dalio's fund was down 16% in March; Robert Gibbins' was down 20%. → Read More

Cash Is King In The Time Of Coronavirus

Investors are rushing into money market funds and corporations have tapped their credit lines. → Read More